公司資料
GE HealthCare Technologies Inc. 股價、新聞與催化劑
- 股票代碼:
- GEHC
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
63.98 USD (-2.13%)
收盤價
最後更新: 2026年10月1日
28.2B USD
市值
股價為何變動
截至 2026年10月1日，GEHC 下跌 2.13%，收於 $63.98。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Global Medical Technology Company
GE HealthCare provides medical imaging, pharmaceutical diagnostics, patient monitoring, ultrasound, and healthcare software. Its products and services support diagnosis, therapy planning, clinical decision-making, and longitudinal patient management.
Advanced Imaging Solutions
Advanced Imaging Solutions includes magnetic resonance, computed tomography, molecular imaging, ultrasound, image-guided therapy, and advanced visualization. The segment combines large installed equipment with software upgrades, service contracts, and procedure-driven utilization.
Pharmaceutical Diagnostics
Pharmaceutical Diagnostics supplies contrast media and molecular imaging agents used with imaging systems. This business links diagnostic pharmaceuticals with the company's scanner installed base and provides recurring revenue tied to patient procedures.
Patient Care Solutions
Patient Care Solutions includes monitoring, maternal and infant care, anesthesia delivery, diagnostic cardiology, and related technologies. These products are used across hospitals, intensive care units, operating rooms, and ambulatory settings.
AI, Cloud, and Precision Care
GE HealthCare integrates artificial intelligence, cloud software, and workflow tools into imaging and clinical systems. Its strategy is to help clinicians interpret data, automate repetitive tasks, personalize diagnosis and therapy, and connect information across care settings.
未來催化劑
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。